Aloha Laser Vision Becomes First in Hawaii to Offer New Keratoconus Treatment
Aloha Laser Vision in Honolulu, Hawaii, is the first in the state to offer Epioxa®, a new treatment for Keratoconus.
Honolulu, HI, November 4, 2026 —
Aloha Laser Vision, located in Honolulu, Hawaii, has introduced Epioxa®, a new treatment option for patients diagnosed with Keratoconus. This marks the first time the treatment has been made available in the state of Hawaii.
Keratoconus is a progressive eye condition characterized by the thinning and bulging of the cornea, the clear front surface of the eye. This bulging causes blurred and distorted vision. While the exact cause of Keratoconus is not fully understood, it typically begins in the teenage years or early twenties and can worsen over time.
The introduction of Epioxa® at Aloha Laser Vision provides a new therapeutic avenue for individuals seeking to manage this condition. The specific details regarding the mechanism of action for Epioxa®, the timeline for its availability, or any clinical trial outcomes were not provided. Furthermore, information concerning the medical professionals who will administer the treatment or patient eligibility criteria was not detailed in the initial announcement.
Aloha Laser Vision’s status as the first provider of Epioxa® in Hawaii signifies a local advancement in eye care for Keratoconus patients. The clinic’s location in Honolulu serves the broader Hawaiian Islands. Further details about the treatment, including its potential benefits and application, are expected to be made available by the clinic.
Story summarized from the original created by Google News on news.google.com, see more information here.
